Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026

Rhea-AI Summary

Bioventus (Nasdaq: BVS) will release its second quarter fiscal 2026 financial results before the market opens on Wednesday, August 5, 2026. Management will host a conference call at 8:30 a.m. Eastern Time the same day, with live webcast and materials available via the company’s Investor Relations website. The webcast replay will be archived until August 4, 2027.

News Market Reaction – BVS

-0.68%

-0.68% Session close to close

In the Jul 29 session, BVS declined 0.68%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical earnings-date reactions were -2.91% and +0.34%. This scheduling notice adds timing, while...

Analysis

Historical earnings-date reactions were -2.91% and +0.34%. This scheduling notice adds timing, while the platform record shows inconsistent responses; the key risk is that no Q2 financial results are disclosed yet.

Key Figures

Reporting Period: Q2 fiscal year 2026 Results Date: August 5, 2026 Conference Call Time: 8:30 a.m. Eastern Time +3 more

6 metrics

Reporting Period Q2 fiscal year 2026 Financial results announcement

Results Date August 5, 2026 Before the market opens

Conference Call Time 8:30 a.m. Eastern Time August 5, 2026

Conference ID 8813117 Bioventus conference call

Call-In Number 1-800-715-9871 Conference call participation

Replay Availability August 4, 2027 Webcast archive availability through this date

Previous Earnings date Reports

2 past events · Latest: Apr 28 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 28	Earnings date	Neutral	-2.9%	Announced first-quarter fiscal 2026 results date and conference call details
Feb 24	Earnings date	Neutral	+0.3%	Announced fourth-quarter fiscal 2025 results date and investor access details

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior tag-matched earnings-date announcements produced mixed reactions, ranging from -2.91% to +0.34%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2026 before the market opens on Wednesday, August 5, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-800-715-9871 and refer to the Bioventus Inc. Conference Call or the Conference ID 8813117.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until August 4, 2027.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com  

FAQ

When will Bioventus (BVS) report its Q2 fiscal 2026 financial results?

Bioventus will report Q2 fiscal 2026 financial results on Wednesday, August 5, 2026, before the market opens. According to Bioventus, the release will be followed by a management conference call and webcast that same morning.

What time is the Bioventus (BVS) Q2 2026 earnings conference call?

The Bioventus Q2 fiscal 2026 earnings conference call starts at 8:30 a.m. Eastern Time on August 5, 2026. According to Bioventus, management will discuss quarterly results and provide a business update during this call.

How can investors join the Bioventus (BVS) Q2 2026 earnings call by phone?

Investors can join by dialing 1-800-715-9871 and referencing the Bioventus Conference Call or Conference ID 8813117. According to Bioventus, this phone access connects participants directly to the live earnings discussion and Q2 2026 business update.

Where can I access the Bioventus (BVS) Q2 2026 earnings webcast and materials?

The Q2 fiscal 2026 earnings webcast and materials will be available on the Bioventus Investor Relations website at https://ir.bioventus.com/. According to Bioventus, investors can stream the live call and review accompanying presentation documents there.

Will a replay of the Bioventus (BVS) Q2 2026 earnings call be available?

Yes, a replay of the Q2 fiscal 2026 earnings webcast will be archived on the Bioventus Investor Relations site. According to Bioventus, this replay will remain accessible for investors until August 4, 2027 for on-demand listening.

What will Bioventus (BVS) management discuss on the August 5, 2026 call?

Management will discuss Bioventus’ Q2 fiscal 2026 financial results and provide a business update. According to Bioventus, the August 5, 2026 conference call and webcast are designed to brief investors on quarterly performance and current company developments.